Product
Human umbilical cord-derived mesenchymal stem cell
1 clinical trial
1 indication
Indication
CirrhosisClinical trial
A Phase I, Open-label Trial on the Safety and Efficacy of Human Umbilical Cord-derived Mesenchymal Stem Cell Administration in the Management of Adult Liver CirrhosisStatus: Completed, Estimated PCD: 2022-08-30